Syndax Pharmaceuticals (SNDX) Misses Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Join SI Premium – FREE
Syndax Pharmaceuticals (NASDAQ: SNDX) reported Q4 EPS of ($1.00), $0.03 worse than the analyst estimate of ($0.97).
For earnings history and earnings-related data on Syndax Pharmaceuticals (SNDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- Qualcomm expects $40bn in non-handset revenue by fiscal 2029
- NRC Health (NRC) Reiterated at Market Outperform by Citizens Ahead of Annual Forum
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
